Friday 27th January 2012 |
Text too small? |
The Financial Markets Authority is giving all issuers of investments to the public until Jan. 1 next year to get all their prospectuses and investment statements to comply with the new financial markets conduct law.
The financial markets watchdog has also issued guidelines for issuers to help them meet the new test of “clear, concise, effective” documents that help ordinary members of the public decide whether to invest their money.
Among requirements are some learnt from recent experiences in the finance company and KiwiSaver sectors. For example, all KiwiSaver funds must report any fee rebates or non-core income that could be boosting its returns artificially.
Submissions are sought on the 59 page consultation document by March 9, but they will apply from May 1, the FMA said. That is one month after the FMA drops the vetting service it used to provide for companies, in favour of simple, clear guidelines on information to include.
Plain English writing is urged, and the use of photographs and brand imagery is discouraged unless necessary to explain the offer. The FMA suggests spacing, colour and font choice are as racy as most of a prospectus or investment statement should be.
For related party transactions, the FMA says it will apply New Zealand accounting standard IAS 24.
“If this is not used in a disclosure document, then we propose to require an issuer to disclose that they are using a different definition and why.”
All new investment documents issued from May 1 will have to comply with the guidelines, and other issuers will have until Jan.1 2013 to update their investment materials.
It had earlier thought updating could be achieved b y Oct. 1, but decided there it would be less of cost burden to issuers and investors to allow an extra two months.
(BusinessDesk)
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report